Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Investigations into Hypoxia and Oxidative Stress at the Optic Nerve Head in a Rat Model of Glaucoma.

Chidlow G, Wood JPM, Casson RJ.

Front Neurosci. 2017 Aug 24;11:478. doi: 10.3389/fnins.2017.00478. eCollection 2017.

2.

Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.

Chiasseu M, Alarcon-Martinez L, Belforte N, Quintero H, Dotigny F, Destroismaisons L, Vande Velde C, Panayi F, Louis C, Di Polo A.

Mol Neurodegener. 2017 Aug 3;12(1):58. doi: 10.1186/s13024-017-0199-3.

3.

Role of BDNF/TrkB pathway in the visual system: Therapeutic implications for glaucoma.

Mysona BA, Zhao J, Bollinger KE.

Expert Rev Ophthalmol. 2017;12(1):69-81. doi: 10.1080/17469899.2017.1259566. Epub 2016 Nov 23.

PMID:
28751923
4.

Interleukin-6 Deficiency Attenuates Retinal Ganglion Cell Axonopathy and Glaucoma-Related Vision Loss.

Echevarria FD, Formichella CR, Sappington RM.

Front Neurosci. 2017 May 31;11:318. doi: 10.3389/fnins.2017.00318. eCollection 2017.

5.

Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension.

Vidal-Sanz M, Galindo-Romero C, Valiente-Soriano FJ, Nadal-Nicolás FM, Ortin-Martinez A, Rovere G, Salinas-Navarro M, Lucas-Ruiz F, Sanchez-Migallon MC, Sobrado-Calvo P, Aviles-Trigueros M, Villegas-Pérez MP, Agudo-Barriuso M.

Front Neurosci. 2017 Apr 26;11:235. doi: 10.3389/fnins.2017.00235. eCollection 2017. Review.

6.

Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective.

Harder JM, Braine CE, Williams PA, Zhu X, MacNicoll KH, Sousa GL, Buchanan RA, Smith RS, Libby RT, Howell GR, John SWM.

Proc Natl Acad Sci U S A. 2017 May 9;114(19):E3839-E3848. doi: 10.1073/pnas.1608769114. Epub 2017 Apr 26.

7.

Metabolic Vulnerability in the Neurodegenerative Disease Glaucoma.

Inman DM, Harun-Or-Rashid M.

Front Neurosci. 2017 Mar 30;11:146. doi: 10.3389/fnins.2017.00146. eCollection 2017. Review.

8.

The connective tissue phenotype of glaucomatous cupping in the monkey eye - Clinical and research implications.

Yang H, Reynaud J, Lockwood H, Williams G, Hardin C, Reyes L, Stowell C, Gardiner SK, Burgoyne CF.

Prog Retin Eye Res. 2017 Jul;59:1-52. doi: 10.1016/j.preteyeres.2017.03.001. Epub 2017 Mar 12. Review.

PMID:
28300644
9.

Structural and functional brain changes in early- and mid-stage primary open-angle glaucoma using voxel-based morphometry and functional magnetic resonance imaging.

Jiang MM, Zhou Q, Liu XY, Shi CZ, Chen J, Huang XH.

Medicine (Baltimore). 2017 Mar;96(9):e6139. doi: 10.1097/MD.0000000000006139.

10.

Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma.

Lambert WS, Carlson BJ, Formichella CR, Sappington RM, Ahlem C, Calkins DJ.

Front Neurosci. 2017 Feb 7;11:45. doi: 10.3389/fnins.2017.00045. eCollection 2017.

11.

Astrocytes in the Optic Nerve Head of Glaucomatous Mice Display a Characteristic Reactive Phenotype.

Wang R, Seifert P, Jakobs TC.

Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):924-932. doi: 10.1167/iovs.16-20571.

12.

Loss of Fractalkine Signaling Exacerbates Axon Transport Dysfunction in a Chronic Model of Glaucoma.

Breen KT, Anderson SR, Steele MR, Calkins DJ, Bosco A, Vetter ML.

Front Neurosci. 2016 Nov 24;10:526. eCollection 2016.

13.

Early Cytoskeletal Protein Modifications Precede Overt Structural Degeneration in the DBA/2J Mouse Model of Glaucoma.

Wilson GN, Smith MA, Inman DM, Dengler-Crish CM, Crish SD.

Front Neurosci. 2016 Nov 3;10:494. eCollection 2016.

14.

Interleukin-6: A Constitutive Modulator of Glycoprotein 130, Neuroinflammatory and Cell Survival Signaling in Retina.

Echevarria FD, Rickman AE, Sappington RM.

J Clin Cell Immunol. 2016 Aug;7(4). pii: 439. Epub 2016 Jul 22.

15.

Magnetization transfer imaging reveals geniculocalcarine and striate area degeneration in primary glaucoma: a preliminary study.

Zhang Y, Liang W, Wu G, Zhang X, Wen G.

Acta Radiol Open. 2016 Sep 8;5(9):2058460116666876. doi: 10.1177/2058460116666876. eCollection 2016 Sep.

16.

Selective Vulnerability of Specific Retinal Ganglion Cell Types and Synapses after Transient Ocular Hypertension.

Ou Y, Jo RE, Ullian EM, Wong RO, Della Santina L.

J Neurosci. 2016 Aug 31;36(35):9240-52. doi: 10.1523/JNEUROSCI.0940-16.2016.

17.

Glaucoma: the retina and beyond.

Davis BM, Crawley L, Pahlitzsch M, Javaid F, Cordeiro MF.

Acta Neuropathol. 2016 Dec;132(6):807-826. Epub 2016 Aug 20. Review.

18.

Retinal Structures and Visual Cortex Activity are Impaired Prior to Clinical Vision Loss in Glaucoma.

Murphy MC, Conner IP, Teng CY, Lawrence JD, Safiullah Z, Wang B, Bilonick RA, Kim SG, Wollstein G, Schuman JS, Chan KC.

Sci Rep. 2016 Aug 11;6:31464. doi: 10.1038/srep31464.

19.

Distal retinal ganglion cell axon transport loss and activation of p38 MAPK stress pathway following VEGF-A antagonism.

Foxton R, Osborne A, Martin KR, Ng YS, Shima DT.

Cell Death Dis. 2016 May 5;7:e2212. doi: 10.1038/cddis.2016.110.

20.

In vitro and in vivo neuroprotective effects of cJun N-terminal kinase inhibitors on retinal ganglion cells.

Kim BJ, Silverman SM, Liu Y, Wordinger RJ, Pang IH, Clark AF.

Mol Neurodegener. 2016 Apr 21;11:30. doi: 10.1186/s13024-016-0093-4.

Supplemental Content

Support Center